Zealand Pharma

  • 2008

    12 February 2008: Press release no. 1, 2008: Phase III program for AVE0010/ZP10 licensed ...

    Read More >

  • Product Pipeline

    Pipeline with 1 compound in phase III, 2 compounds in phase II, 2 compounds in phase I and ...

    Read More >

  • Available Positions

    We have one vacant position:  Scientist - Peptide Chemistry  

    Read More >

Zealand Pharma

Zealand Pharma is a biopharmaceutical company dedicated to the discovery and development of innovative peptide-based drugs. The products target diseases and symptoms of significant unmet clinical need and commercial potential.

Since 1999, Zealand’s scientists have built a pipeline that includes three compounds in clinical phase II development and two compounds in clinical phase I development. In addition, two compounds are in pre-clinical development.

As part of the Company’s operations, Zealand Pharma has formed clinical development partnerships with leading pharmaceutical companies Sanofi-Aventis and Wyeth.

Zealand Pharma is based in Copenhagen and has approximately 65 employees.

Annual Report 2007   
    

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Drugs